Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organic Chromium Supplementation in Type 2 Diabetes Mellitus
NCT00145093Phase 3Completed
- Sponsor
- Medical Research Foundation
- Start
- Aug 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Chromium yeast with Placebo (2 arms). Primary endpoints: Hemoglobin A1c at 6 months, Fasting glucose at 6 months and 1 more. Started Aug 2004; status: completed.
02
Drugs
chromium yeast
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00145093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145093.